Raising awareness about primary TAS, a rare and aggressive mesenchymal tumor, is important so that early diagnosis and undelayed radical surgery along with complementary radiation are possible. Extending the existing knowledge on the course and final outcome of the disease may help identify the best treatment approach to improve survival.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813081 | PMC |
http://dx.doi.org/10.1002/ccr3.3492 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!